Zelboraf 240 MG tablet UU 112S
Ended Awarded
- Contract number
- SPE2DB25FQWPE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,335
Award facts
- Contract value 100% obligated
- $8,335.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,335.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zelboraf 240 mg tablets (112 units). This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, was awarded without a set-aside designation. The order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for government healthcare contracts. The company's portfolio includes delivery of branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories. Zelboraf, an oncology medication, aligns with the company's demonstrated capability in providing specialized pharmaceutical products to Department of Defense healthcare sites. The vendor has maintained consistent contract awards with the Defense Logistics Agency since its SAM.gov registration in 2001, reflecting its reliability and established position as a trusted pharmaceutical distributor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FQWPE?
SPE2DB25FQWPE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FQWPE worth?
The government has obligated $8,335 on SPE2DB25FQWPE.
Is contract SPE2DB25FQWPE an order under another contract?
Yes. SPE2DB25FQWPE is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWPE competed?
The extent of competition for SPE2DB25FQWPE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award